To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: Midazolam|DRUG: Lapatinib
Sponsor: GlaxoSmithKline